Concepedia

Anca‐Maria Albici

AA

Statistics

Publications

3

Citations

143

H-Index

3

Active since

2024

Affiliations

University Hospital Leipzig(Current)

University Medical Center Hamburg-Eppendorf

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

University of Lübeck

Hospital Clínic de Barcelona

Anca‐Maria Albici is an author at University Hospital Leipzig specializing in multiple myeloma treatment, oncology, and immunotherapy.

Publications per year

2024–2025

3

Publications

3

Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

Nico Gagelmann, Danai Dima, Maximilian Merz et al. · Journal of Clinical Oncology · 2024 · 83 citations · Full text

, , +17

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study

Maximilian Merz, Anca‐Maria Albici, Bastian von Tresckow et al. · HemaSphere · 2025 · 38 citations · Full text

, , +13

Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy

Maximilian Merz, Danai Dima, Hamza Hashmi et al. · Blood Cancer Journal · 2024 · 22 citations · Full text

, , +17

1–3 of 3